Press Room
2025-08-08
Duchesnay Pharmaceutical Group has accumulated 18 months' worth of stock in the US to support American patients
“Since January, DPG has increased its stocks in the US to 18 months so as not to penalize American patients who use our products and who will have to bear the price increases.” The President of Duchesnay Pharmaceutical Group shared the strategy adopted by the Group in anticipation of the possible introduction of US tariffs on imported drugs with Jean-Philippe Décarie, economic columnist at La Presse.
More details in the article in La Presse (in French only): click here
